首页> 外文期刊>The journal of clinical endocrinology and metabolism >The Growth Hormone Receptor (GHR) c.899dupC Mutation Functions as a Dominant Negative: Insights into the Pathophysiology of Intracellular GHR Defects
【24h】

The Growth Hormone Receptor (GHR) c.899dupC Mutation Functions as a Dominant Negative: Insights into the Pathophysiology of Intracellular GHR Defects

机译:生长激素受体(GHR)c.899dupC突变作为一个主要的负面作用:细胞内GHR缺陷的病理生理学见解。

获取原文
       

摘要

Context:GH insensitivity (GHI) is a condition characterized by pronounced IGF-I deficiency and severe short stature. We previously identified a novel compound heterozygous GH receptor ( GHR ) mutation, GHR:p.R229H/ c.899dupC , in a patient presenting with GHI. The heterozygous p.R229H (prepeptide) variant was previously associated with GHI despite a lack of adequate functional studies. The novel heterozygous GHR: c.899dupC variant affects the critical JAK2-binding Box 1 region of the GHR intracellular domain; the duplication predicted a frameshift and early protein termination.
机译:背景:GH不敏感性(GHI)是一种以明显的IGF-I缺乏和严重的身材矮小为特征的疾病。我们之前在患有GHI的患者中鉴定了一种新型的复合杂合GH受体(GHR)突变GHR:p.R229H / c.899dupC。尽管缺乏足够的功能研究,但杂合的p.R229H(前肽)变体先前与GHI相关。新型杂合GHR:c.899dupC变体影响GHR细胞内结构域的关键JAK2结合框1区域;该重复预测了移码和蛋白质早期终止。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号